Key result
Desipramine is linked to a fourth pediatric sudden death, potentially driven by long QT syndrome.
Why the study?
Considerable uncertainty remains about the basis of the apparent association between desipramine use and sudden death in children with behavioral disorders.
Does desipramine cause sudden death in children?
Case Report (n=4)
Does desipramine cause sudden death in children?
This case series highlights a potential association between desipramine use in children and sudden death, possibly mediated by long QT syndrome.
Answers are grounded in this paper and cite their sources.
Should not yet change desipramine prescribing in children; hypothesis-generating for long QT-mediated sudden death.
The sudden death of three children receiving the tricyclic antidepressant medication desipramine for behavioral disorders was reported in 1990. We now provide new information about these children and describe a fourth case. Because desipramine is a useful medication for many children, these deaths pose clinical dilemmas for physicians and families. The cardiac long QT syndrome has been proposed as a mechanism for these sudden deaths. Considerable uncertainty remains about the basis of the apparent association between the use of desipramine and the sudden deaths.
No takes yet. Share an insight, caveat, or question.
Riddle et al. (1993) conducted a case report in Behavioral disorders (n=4). Desipramine was evaluated on Sudden death. Desipramine use in children for behavioral disorders was associated with a fourth reported case of sudden death, with cardiac long QT syndrome proposed as a potential mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: